| Renee S Gibbs, CRNA | |
|
2201 Lexington Ave, Ashland, KY 41101-2843 | |
| (606) 408-4000 | |
| Not Available |
| Full Name | Renee S Gibbs |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 2201 Lexington Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346859626 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3014823 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
| Northstar Anesthesia Of West Virginia Pllc | 2668750241 | 112 |
News Archive
They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
Save the Children on Monday released a report examining "the four major barriers that prevent mothers from breastfeeding" - community and cultural pressures, the shortage of health workers, a lack of maternity legislation, and inappropriate promotion of breast-milk substitutes."
› Verified 5 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
Save the Children on Monday released a report examining "the four major barriers that prevent mothers from breastfeeding" - community and cultural pressures, the shortage of health workers, a lack of maternity legislation, and inappropriate promotion of breast-milk substitutes."
› Verified 5 days ago
| Entity Name | Riverside Anesthesia Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578946596 PECOS PAC ID: 3072828193 Enrollment ID: O20150819007441 |
News Archive
They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
Save the Children on Monday released a report examining "the four major barriers that prevent mothers from breastfeeding" - community and cultural pressures, the shortage of health workers, a lack of maternity legislation, and inappropriate promotion of breast-milk substitutes."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renee S Gibbs, CRNA 425 Lewis Hargett Cir, Lexington, KY 40503-3590 Ph: (859) 268-1030 | Renee S Gibbs, CRNA 2201 Lexington Ave, Ashland, KY 41101-2843 Ph: (606) 408-4000 |
News Archive
They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
Save the Children on Monday released a report examining "the four major barriers that prevent mothers from breastfeeding" - community and cultural pressures, the shortage of health workers, a lack of maternity legislation, and inappropriate promotion of breast-milk substitutes."
› Verified 5 days ago
Stephanie A. Burgess, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1000 Saint Christopher Dr, Ashland, KY 41101 Phone: 606-833-3791 | |
Gabriel Donald Ramsey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Avenue, Ashland, KY 41101 Phone: 606-327-4000 | |
Jason G. Ellis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Vickie Lynn Blair, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2201 Lexington Avenue, Ashland, KY 41101 Phone: 606-327-4000 | |
Joshua W Wells, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 859-408-4000 | |
Jodie L. Workman, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Brandi L. Sperry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 |